Evidence map›Paper›PMID 37872640›Full record

ArticleGenome medicine2023

Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions.

Katherine S Josephs, Angharad M Roberts, Pantazis Theotokis, Roddy Walsh, Philip J Ostrowski, Matthew Edwards, Andrew Fleming, Courtney Thaxton, Jason D Roberts, Melanie Care and 25 more

Abstract read
In one paragraph

Article in Genome medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Natural History, Phenotype Spectrum, and Clinical Outcomes of Desmin (Circulation. Genomic and precision medicine · 2025
    Pooled it
  2. What Should a Clinical Cardiologist Know About Cardiogenetics?Journal of the American Heart Association · 2025
    Review
  3. Circulating Cardiovascular Proteomic Associations With Genetics and Disease.Circulation. Genomic and precision medicine · 2025
    Article
  4. Article
  5. Article
  6. Sex Differences in the Genetic Causes of Dilated Cardiomyopathy.Journal of the American College of Cardiology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Natural History, Phenotype Spectrum and Clinical Outcomes of Desmin (medRxiv : the preprint server for health sciences · 2024
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors.

Katherine S JosephsNational Heart and Lung Institute, Imperial College London, Du Cane Road, London, W12 0NN, UK.ORCID http://orcid.org/0000-0001-7688-615X
Angharad M RobertsNational Heart and Lung Institute, Imperial College London, Du Cane Road, London, W12 0NN, UK.
Pantazis TheotokisNational Heart and Lung Institute, Imperial College London, Du Cane Road, London, W12 0NN, UK.
Roddy WalshAmsterdam University Medical Centre, University of Amsterdam, Heart Center, Department of Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
Philip J OstrowskiGreat Ormond Street Hospital, NHS Foundation Trust, London, UK.
Matthew EdwardsClinical Genetics & Genomics Lab, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Andrew FlemingClinical Genetics & Genomics Lab, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Courtney ThaxtonDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jason D RobertsPopulation Health Research Institute, McMaster University, and Hamilton Health Sciences, Hamilton, Ontario, Canada.
Melanie CareDepartment of Molecular Genetics, University of Toronto, Toronto, Canada.
Wojciech ZarebaClinical Cardiovascular Research Center, University of Rochester, Rochester, NY, USA.
Arnon AdlerDivision of Cardiology, Peter Munk Cardiac Centre, University Health Network and Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Amy C Sturm23andMe, Genomic Health, Sunnyvale, CA, USA.
Rafik TadrosCardiovascular Genetics Center, Montreal Heart Institute, and Faculty of Medicine, Université de Montréal, Montreal, Canada.
Valeria NovelliUnit of Immunology and Functional Genomics, Centro Cardiologico Monzino IRCCS, Milano, Italy.
Emma OwensDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Lucas BronickiDepartment of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Olga JarinovaDepartment of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Bert CallewaertCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Stacey PetersDepartment of Cardiology and Genomic Medicine, Royal Melbourne Hospital, Melbourne, Australia.
Tom LumbersBarts Health & University College London Hospitals NHS Trusts, London, UK.
Elizabeth JordanDivisions of Human Genetics and Cardiovascular Medicine, The Ohio State University, Columbus, OH, USA.
Babken AsatryanDepartment of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Neesha KrishnanCentre for Population Genomics, Garvan Institute of Medical Research, and UNSW Sydney, Sydney, Australia.
Ray E HershbergerDivisions of Human Genetics and Cardiovascular Medicine, The Ohio State University, Columbus, OH, USA.
C Anwar A ChahalCenter for Inherited Cardiovascular Diseases, WellSpan Health, Lancaster, PA, USA.
Andrew P LandstromDepartment of Pediatrics and Cell Biology, Duke University School of Medicine, Durham, NC, USA.
Cynthia JamesJohns Hopkins Center for Inherited Heart Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Elizabeth M McNallyCenter for Genetic Medicine, Dept of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Daniel P JudgeMedical University of South Carolina, Charleston, SC, USA.
Peter van TintelenDepartment of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.
Arthur WildeDepartment of Cardiology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.
Michael GollobInherited Arrhythmia and Cardiomyopathy Program, Division of Cardiology, University of Toronto, Toronto, ON, Canada.
Jodie InglesCentre for Population Genomics, Garvan Institute of Medical Research, and UNSW Sydney, Sydney, Australia.
James S WareNational Heart and Lung Institute, Imperial College London, Du Cane Road, London, W12 0NN, UK. j.ware@imperial.ac.uk.

Funding

The Clinical Genome Resource – Advancing genomic medicine through biocuration and expert assessment of genes and variants at scaleU24HG009650 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JONATHAN S BERG, Jessica Ezzell Hunter · 2021 to 2026
$30.0M
Cardiomyopathy Genomes ProjectR01HL128075 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MCNALLY, ELIZABETH M, NOBREGA, MARCELO A. · 2015 to 2023
$5.3M
British Heart Foundation FS/CRLF/21/23011British Heart Foundation RE/18/4/34215Medical Research Council MC_UP_1102/20Medical Research Council MR/S003754/1NHGRI NIH HHS U24 HG009650NHLBI NIH HHS R01 HL128075Wellcome TrustWellcome Trust 107469/Z/15/ZWellcome Trust 200990/A/16/ZWellcome Trust 222883/Z/21/Z
6 · The paper itself

Abstract

backgroundAs the availability of genomic testing grows, variant interpretation will increasingly be performed by genomic generalists, rather than domain-specific experts. Demand is rising for laboratories to accurately classify variants in inherited cardiac condition (ICC) genes, including secondary findings.

methodsWe analyse evidence for inheritance patterns, allelic requirement, disease mechanism and disease-relevant variant classes for 65 ClinGen-curated ICC gene-disease pairs. We present this information for the first time in a structured dataset, CardiacG2P, and assess application in genomic variant filtering.

resultsFor 36/65 gene-disease pairs, loss of function is not an established disease mechanism, and protein truncating variants are not known to be pathogenic. Using the CardiacG2P dataset as an initial variant filter allows for efficient variant prioritisation whilst maintaining a high sensitivity for retaining pathogenic variants compared with two other variant filtering approaches.

conclusionsAccess to evidence-based structured data representing disease mechanism and allelic requirement aids variant filtering and analysis and is a pre-requisite for scalable genomic testing.

Indexed as

Genetic TestingGenetic VariationDatabases, GeneticGenomicsHumansInheritance PatternsAllelic requirementDisease mechanismGene curationGenomic variant filteringInheritanceInherited cardiac conditionsVariant classificationVariant interpretation

Identifiers

PMID37872640
PMCPMC10594882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.